Cigna Investments’s Exelixis EXEL Stock Holding History

Cigna Investments’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,658	Closed	-$204K	–	673
2021 Q3	$204K	Buy	+9,658	New	+$179K	0.02%	708
2021 Q2	–	Sell	-11,158	Closed	-$252K	–	756
2021 Q1	$252K	Buy	11,158 +555	+5%	+$12.5K	0.02%	655
2020 Q4	$212K	Buy	10,603 +957	+10%	+$20K	0.02%	674
2020 Q3	$237K	Sell	9,646 -6,189	-39%	-$144K	0.02%	549
2020 Q2	$375K	Buy	+15,835	New	+$367K	0.04%	476
2019 Q2	–	Sell	-11,845	Closed	-$282K	–	682
2019 Q1	$282K	Buy	+11,845	New	+$270K	0.03%	548
2018 Q3	–	Sell	-14,067	Closed	-$302K	–	752
2018 Q2	$302K	Buy	+14,067	New	+$291K	0.02%	587
2018 Q1	–	Sell	-9,569	Closed	-$291K	–	840
2017 Q4	$291K	Sell	9,569 -72	-0.7%	-$1.92K	0.02%	700
2017 Q3	$233K	Sell	9,641 -214	-2%	-$5.7K	0.02%	771
2017 Q2	$243K	Buy	+9,855	New	+$209K	0.02%	697

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cigna Investments's EXEL Position: Q4 2021 in Review

Cigna Investments sold out of Exelixis (EXEL) in Q4 2021, closing a stake of 9,658 shares — an estimated $204K sold.

Cigna Investments first reported a position in EXEL in Q2 2017 and held it in 10 quarters. The position peaked at $375K in Q2 2020. 328 funds tracked by Wall St. Rank hold EXEL as of Q4 2021.

Cigna Investments reported no remaining Exelixis position as of Q4 2021 after selling out during the quarter.
Cigna Investments sold 9,658 Exelixis shares in Q4 2021, an estimated $204K.
Cigna Investments first reported a position in Exelixis in Q2 2017 and held it in 10 quarters.
Cigna Investments's Exelixis position peaked at $375K in Q2 2020.
328 funds tracked by Wall St. Rank held Exelixis as of Q4 2021.

Based on Cigna Investments's 13F filing for Q4 2021, filed 14 Feb 2022.